Skip to main content

Intrexon Raises $100M in Series E Round

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic biology firm Intrexon today announced the close of its Series E round of financing, which raised $100 million and brings the total capital raised by the company in its history to more than $259 million.

Proceeds will be used for working capital and for the expansion of the company's UltraVector platform, the underlying architecture and construction methodology for Intrexon's complex transgenes, the company said. The platform is "the backbone" of its work in human healthcare, animal science, agricultural biotechnology, and industrial products.

The majority of the investment in the round was made by new investors. Existing ones, including Randal Kirk, Intrexon's chairman and CEO, and Third Security also participated. Perella Weinberg Partners was Intrexon's exclusive financial advisor and placement agent.

"Given the vast scope of applications that are amenable to biological synthesis, Intrexon's unparalleled ability to produce gene programs for the control of cellular function, and our scalability, I believe that Intrexon today represents one of the most exciting endeavors in all of life sciences," Kirk said in a statement.

In documents filed with the US Securities and Exchange Commission last month, the company disclosed it had raised $66.9 million. It is unclear whether those funds were part of the round announced today.

In January 2010, Intrexon announced it had raised $25 million in equity financing.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.